142 related articles for article (PubMed ID: 9120930)
1. Prostate specific antigen density of the transition zone: a new effective parameter for prostate cancer prediction.
Zlotta AR; Djavan B; Marberger M; Schulman CC
J Urol; 1997 Apr; 157(4):1315-21. PubMed ID: 9120930
[TBL] [Abstract][Full Text] [Related]
2. Prostate specific antigen density of the transition zone for early detection of prostate cancer.
Djavan B; Zlotta AR; Byttebier G; Shariat S; Omar M; Schulman CC; Marberger M
J Urol; 1998 Aug; 160(2):411-8; discussion 418-9. PubMed ID: 9679889
[TBL] [Abstract][Full Text] [Related]
3. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.
Djavan B; Zlotta A; Remzi M; Ghawidel K; Basharkhah A; Schulman CC; Marberger M
J Urol; 2000 Apr; 163(4):1144-8; discussion 1148-9. PubMed ID: 10737484
[TBL] [Abstract][Full Text] [Related]
4. PSA density and PSA transition zone density in the diagnosis of prostate cancer in PSA gray zone cases.
Aksoy Y; Oral A; Aksoy H; Demirel A; Akcay F
Ann Clin Lab Sci; 2003; 33(3):320-3. PubMed ID: 12956448
[TBL] [Abstract][Full Text] [Related]
5. Prostate specific antigen density of the transition zone for predicting pathological stage of localized prostate cancer in patients with serum prostate specific antigen less than 10 ng./ml.
Zlotta AR; Djavan B; Petein M; Susani M; Marberger M; Schulman CC
J Urol; 1998 Dec; 160(6 Pt 1):2089-95. PubMed ID: 9817330
[TBL] [Abstract][Full Text] [Related]
6. Impact of PSA density of transition zone as a potential parameter in reducing the number of unnecessary prostate biopsies in patients with psa levels between 2.6 and 10.0 ng/mL.
Castro HAS; Iared W; Santos JEM; Solha RS; Shigueoka DC; Ajzen SA
Int Braz J Urol; 2018; 44(4):709-716. PubMed ID: 29697929
[TBL] [Abstract][Full Text] [Related]
7. [PSA level of the transitional zone: a new marker especially reliable for the detection of prostatic cancer].
Roumeguere T; Zlotta AR; Djavan BR; Marberger M; Schulman CC
Acta Urol Belg; 1997 Mar; 65(1):5-9. PubMed ID: 9245203
[TBL] [Abstract][Full Text] [Related]
8. Comparison of prostate-specific antigen adjusted for transition zone volume versus prostate-specific antigen density in predicting prostate cancer by transrectal ultrasonography.
Sung DJ; Cho SB; Kim YH; Oh YW; Lee NJ; Kim JH; Chung KB; Moon DG
J Ultrasound Med; 2004 May; 23(5):615-22. PubMed ID: 15154527
[TBL] [Abstract][Full Text] [Related]
9. Prostate-specific antigen adjusted for the transition zone volume versus free-to-total prostate-specific antigen ratio in predicting prostate cancer.
Moon DG; Cheon J; Kim JJ; Yoon DK; Koh SK
Int J Urol; 1999 Sep; 6(9):455-62. PubMed ID: 10510891
[TBL] [Abstract][Full Text] [Related]
10. Prostate-specific antigen adjusted for the transition zone volume as a second screening test: a prospective study of 248 cases.
Kang SH; Bae JH; Park HS; Yoon DK; Moon DG; Kim JJ; Cheon J
Int J Urol; 2006 Jul; 13(7):910-4. PubMed ID: 16882054
[TBL] [Abstract][Full Text] [Related]
11. An artificial neural network for prostate cancer staging when serum prostate specific antigen is 10 ng./ml. or less.
Zlotta AR; Remzi M; Snow PB; Schulman CC; Marberger M; Djavan B
J Urol; 2003 May; 169(5):1724-8. PubMed ID: 12686818
[TBL] [Abstract][Full Text] [Related]
12. Correlation between serum prostate specific antigen levels and the volume of the individual glandular zones of the human prostate.
Hammerer PG; McNeal JE; Stamey TA
J Urol; 1995 Jan; 153(1):111-4. PubMed ID: 7526003
[TBL] [Abstract][Full Text] [Related]
13. Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml.
Stamey TA; Johnstone IM; McNeal JE; Lu AY; Yemoto CM
J Urol; 2002 Jan; 167(1):103-11. PubMed ID: 11743285
[TBL] [Abstract][Full Text] [Related]
14. PSA, PSA density, PSA density of transition zone, free/total PSA ratio, and PSA velocity for early detection of prostate cancer in men with serum PSA 2.5 to 4.0 ng/mL.
Djavan B; Zlotta A; Kratzik C; Remzi M; Seitz C; Schulman CC; Marberger M
Urology; 1999 Sep; 54(3):517-22. PubMed ID: 10475364
[TBL] [Abstract][Full Text] [Related]
15. Can complexed prostate specific antigen and prostatic volume enhance prostate cancer detection in men with total prostate specific antigen between 2.5 and 4.0 ng./ml.
Okihara K; Fritsche HA; Ayala A; Johnston DA; Allard WJ; Babaian RJ
J Urol; 2001 Jun; 165(6 Pt 1):1930-6. PubMed ID: 11371884
[TBL] [Abstract][Full Text] [Related]
16. The value of percent free prostate specific antigen, prostate specific antigen density of the whole prostate and of the transition zone in Turkish men.
Akduman B; Alkibay T; Tuncel A; Bozkirli I
Can J Urol; 2000 Oct; 7(5):1104-9. PubMed ID: 11114873
[TBL] [Abstract][Full Text] [Related]
17. [Validity of PSA density of the transition zone in the diagnosis of prostate cancer].
Anastasi G; Magno C; Carmignani A; Inferrera A; Petrelli A; Broccio G
Arch Ital Urol Androl; 2000 Dec; 72(4):190-3. PubMed ID: 11221034
[TBL] [Abstract][Full Text] [Related]
18. Rationale for using serum prostate-specific antigen (PSA) level and PSA density (PSAD) to detect prostatic malignancy in a country with low prostate cancer incidence.
Rahardjo D; Kamil ST; Pakasi LS
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():563-70. PubMed ID: 10895211
[TBL] [Abstract][Full Text] [Related]
19. Comparison of percent free prostate specific antigen and prostate specific antigen density as methods to enhance prostate specific antigen specificity in early prostate cancer detection in men with normal rectal examination and prostate specific antigen between 4.1 and 10 ng./ml.
Morote J; Raventós CX; Lorente JA; Lopez-Pacios MA; Encabo G; de Torres I; Andreu J
J Urol; 1997 Aug; 158(2):502-4. PubMed ID: 9224333
[TBL] [Abstract][Full Text] [Related]
20. [Predictive value of prostate specific antigen density in the detection of prostate cancer in patients with elevated prostate specific antigen levels and normal digital rectal findings or stage A prostate cancer].
Iwaki H; Kajita Y; Shimizu Y; Yamauchi T
Hinyokika Kiyo; 2001 Mar; 47(3):169-74. PubMed ID: 11329957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
